Publication
313P Disease and treatment patterns for advanced cholangiocarcinoma: A multicentric study from Portugal
| dc.contributor.author | Gonçalves, J. C. N. | |
| dc.contributor.author | Freitas, A. R. R. | |
| dc.contributor.author | Fortuna, A. R. | |
| dc.contributor.author | Menezes, M. B. | |
| dc.contributor.author | Gramaça, J. | |
| dc.contributor.author | Fernandes, I. C. Gomes | |
| dc.contributor.author | Ângelo, I. C. | |
| dc.contributor.author | Trabulo, C. F. P. | |
| dc.contributor.author | Sousa, C. Xavier de | |
| dc.contributor.author | Pina, I. M. Matos | |
| dc.date.accessioned | 2024-12-02T11:50:39Z | |
| dc.date.available | 2024-12-02T11:50:39Z | |
| dc.date.issued | 2024-06 | |
| dc.description.abstract | Gemcitabine plus cisplatin (GC) was standard first-line treatment for advanced biliary tract cancers until recently, supported by the UK ABC-02 study. However, TOPAZ-1 showed survival improvement with Durvalumab plus GC. Nevertheless, a significant proportion of patients face challenges with GC tolerability, prompting into alternatives such as gemcitabine and carboplatin (GCb). Moreover, there remains a paucity of stratified data pertaining to cholangiocarcinomas (CCA). We analyzed 5-year trends to determine treatment rates and cisplatin use in the real world. | eng |
| dc.identifier.doi | 10.1016/j.annonc.2024.05.456 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.uri | http://hdl.handle.net/10400.1/26371 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.publisher | Elsevier | |
| dc.relation.hasversion | https://www.annalsofoncology.org/article/S0923-7534(24)00595-7/fulltext | |
| dc.relation.ispartof | Annals of Oncology | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.title | 313P Disease and treatment patterns for advanced cholangiocarcinoma: A multicentric study from Portugal | eng |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferenceDate | 2024-06-26 | |
| oaire.citation.conferencePlace | Munich/Gastrointestinal Cancers Congress of the European-Society-for-Medical-Oncology (ESMO) | |
| oaire.citation.endPage | S132 | |
| oaire.citation.issue | Suplemento 1 | |
| oaire.citation.startPage | S131 | |
| oaire.citation.title | Annals of Oncology | |
| oaire.citation.volume | 35 | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Disease and treatment patterns for advanced cholangiocarcinoma.pdf
- Size:
- 121.76 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 3.46 KB
- Format:
- Item-specific license agreed upon to submission
- Description: